Cellular reprogramming: a new approach to modelling Parkinson's disease.

Cellular reprogramming: a new approach to modelling Parkinson's disease.

iPSCs (induced pluripotent stem cells) offer an unparalleled opportunity to generate and study physiologically relevant cell types in culture. iPSCs can be generated by reprogramming almost any somatic cell type using pluripotency factors such as Oct4, SOX2, Nanog and Klf4. By reprogramming cells fr...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hartfield, E, Fernandes, H, Vowles, J, Cowley, S, Wade-Martins, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

Physiological characterisation of human iPS-derived dopaminergic neurons
de réir: Hartfield, E, et al.
Foilsithe / Cruthaithe: (2014)

Physiological characterisation of human iPS-derived dopaminergic neurons
de réir: Hartfield, E, et al.
Foilsithe / Cruthaithe: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool.
de réir: Badger, J, et al.
Foilsithe / Cruthaithe: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool
de réir: Badger, J, et al.
Foilsithe / Cruthaithe: (2014)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
de réir: Zambon, F, et al.
Foilsithe / Cruthaithe: (2019)

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease
de réir: Keane, H, et al.
Foilsithe / Cruthaithe: (2015)

Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.
de réir: Vazquez-Arango, P, et al.
Foilsithe / Cruthaithe: (2016)

Physiological characterisation of human iPS-derived dopaminergic neurons.
de réir: Elizabeth M Hartfield, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
de réir: Sandor, C, et al.
Foilsithe / Cruthaithe: (2017)

Cell reprogramming therapy for Parkinson’s disease
de réir: Wenjing Dong, et al.
Foilsithe / Cruthaithe: (2024-01-01)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
de réir: Fernandes, H, et al.
Foilsithe / Cruthaithe: (2016)

Cellular reprogramming for understanding and treating human disease.
de réir: Riya Rajan Kanherkar, et al.
Foilsithe / Cruthaithe: (2014-11-01)

Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
de réir: Joo-Eun Lee, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
de réir: Byounggook Cho, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
de réir: Yiming Wang, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
de réir: Fernandes, H, et al.
Foilsithe / Cruthaithe: (2017)

Are rodent models of Parkinson's disease behaving as they should?
de réir: Vingill, S, et al.
Foilsithe / Cruthaithe: (2017)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
de réir: Chao Zhou, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Network pharmacology of the MPP+ cellular model of Parkinson’s disease
de réir: Keane, H
Foilsithe / Cruthaithe: (2015)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
de réir: Booth, H, et al.
Foilsithe / Cruthaithe: (2019)

Programming and reprogramming cellular identity
de réir: Marson, Alexander
Foilsithe / Cruthaithe: (2008)

Re: Epigenetics of Cellular Reprogramming
de réir: Fehmi Narter
Foilsithe / Cruthaithe: (2016-12-01)

Deterministic versus stochastic model of reprogramming: new evidence from cellular barcoding technique
de réir: Anastasia M. Yunusova, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Convergent pathways in Parkinson’s disease
de réir: Cherubini, M, et al.
Foilsithe / Cruthaithe: (2017)

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair
de réir: Xingyu He, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
de réir: Emma L Lane, et al.
Foilsithe / Cruthaithe: (2008-08-01)

Cellular Reprogramming toward the Erythroid Lineage
de réir: Laura J. Norton, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes
de réir: Lang, C, et al.
Foilsithe / Cruthaithe: (2018)

Epigenetic reprogramming shapes the cellular landscape of schwannoma
de réir: S. John Liu, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Epigenetic determinants of cellular differentiation, transcriptional reprogramming, and human disease
de réir: Nguyen, Khoi Thien.
Foilsithe / Cruthaithe: (2021)

The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
de réir: Bharathi Suresh, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Dynamical systems theory of cellular reprogramming
de réir: Yuuki Matsushita, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Cellular programming and reprogramming - Methods and protocols
de réir: CarloAlberto Redi
Foilsithe / Cruthaithe: (2010-12-01)

Implications of Cellular Aging in Cardiac Reprogramming
de réir: Fabiana Passaro, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Neuroregeneration using in vivo cellular reprogramming
de réir: Tu Nguyen, et al.
Foilsithe / Cruthaithe: (2017-01-01)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
de réir: Booth, H, et al.
Foilsithe / Cruthaithe: (2017)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
de réir: Beevers, J, et al.
Foilsithe / Cruthaithe: (2013)

Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
de réir: J. Drouin-Ouellet, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Exploring the Mitochondrial Degradome by the TAILS Proteomics Approach in a Cellular Model of Parkinson’s Disease
de réir: Marta Lualdi, et al.
Foilsithe / Cruthaithe: (2019-07-01)

New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
de réir: Sonia Lehri-Boufala, et al.
Foilsithe / Cruthaithe: (2015-01-01)